An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERSA UN-backed agency has struck a deal with nearly 30 generic drugmakers to make low-cost versions of Merck's COVID-19 pill molnupiravir for poorer countries, expanding access to a drug seen as a weapon to fight the pandemic.
Cheap Version Of Merck Covid Pill To Be Made For Poorer Nations
noreply@blogger.com (Unknown), TechCrunch
Thu, 01/20/2022 - 5:10am
Topics: ridgeback biotherapeutics lp reuters may co inc/handout reutersa un-backed merck's covid-19 december u.n backed medicines patent pool mpp asia middle east the mpp emory university world health organization who this mpp ceo charles gore bangladesh's beximco pharmaceuticals india's natco pharma south africa's aspen pharmacare china's fosun pharma covid-19 merck co inc ridgeback biotherapeutics india china africa pill poorer cheap version drug generic molnupiravir manufacture companies developed access emergency treatment countries agreement versions drugmakers
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more